NCT03754920

Brief Summary

To determine the feasibility, safety and efficacy of fasting, participants are recruited in a 5-days fasting ( without any food, except unlimited mineral water),and do some fitness regimen (such as meditation and mild physical exercise ) during fasting.The samples will be collected from participates and subjected to comprehensive analysis ,including routine medical examination in blood, metabonomics and proteomics anlysis in serum and urine samples, gut microbiome analysis in stood samples, and so on.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 14, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 27, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2019

Completed
Last Updated

December 4, 2018

Status Verified

October 1, 2018

Enrollment Period

7 months

First QC Date

November 14, 2018

Last Update Submit

November 30, 2018

Conditions

Keywords

prolonged fastingmeditationphysical exercise

Outcome Measures

Primary Outcomes (11)

  • Weight

    Changes in weight will be assessed.

    Day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8; 1 month and 3 months post fasting

  • Blood glucose

    Changes in blood glucose will be assessed.

    Day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8; 1 month and 3 months post fasting

  • Insulin

    Changes in insulin will be assessed.

    Day 0, day 3, day 5, day 8; 1 month and 3 months post fasting

  • Blood pressure

    Changes in blood pressure will be assessed.

    Day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8; 1 month and 3 months post fasting

  • Waistline

    Changes in waistline will be assessed .

    Day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8; 1 month and 3 months post fasting

  • IGF-1

    Changes in IGF-1 will be assessed.

    Day 0, day 3, day 5, day 8; 1 month and 3 months post fasting

  • Pulse Rate

    Changes in pulse rate will be assessed.

    Day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8; 1 month and 3 months post fasting

  • Blood lipid test

    Changes in blood including HDL, LDL, TG, CHO and ect. will be assessed.

    Day 0, day 3, day 5, day 8; 1 month and 3 months post fasting

  • Urine test

    Changes in urine including uric acid and ect. will be assessed.

    Day 0, day 3, day 5, day 8; 1 month and 3 months post fasting

  • Liver and renal function test

    Changes in liver and renal function including AST,ALT,ALP, TP,ALB, Urea, Crea and ect will be assessed at 7:30 am.

    Day 0, day 3, day 5, day 8; 1 month and 3 months post fasting

  • Serum metabolomics analysis

    Serum samples were collected and serum metabolomics (carbohydrate, lipid, amino acid and ect.) were sequenced and analyzed by High-throughput sequencing.

    Day 0, day 3, day 5, day 8; 1 month and 3 months post fasting

Secondary Outcomes (9)

  • Urinary ketone

    Day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8; 1 month and 3 months post fasting

  • Vitamin examination

    Day 0, day 3, day 5, day 8; 1 month and 3 months post fasting

  • Thyroid function

    Day 0, day 3, day 5, day 8; 1 month and 3 months post fasting

  • Inflammatory factors

    Day 0, day 3, day 5, day 8; 1 month and 3 months post fasting

  • Gut microbiome

    Day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8; 1 month and 3 months post fasting

  • +4 more secondary outcomes

Study Arms (1)

prolonged fasting

EXPERIMENTAL

Participants fast for five days, without any food, except unlimited mineral water, and do some fitness regimen(such as meditation and mild physical exercise ).

Behavioral: prolonged fasting

Interventions

Fasting for 5 days: Fasting with some fitness regimen, such as meditation and mild physical exercise; Feeding for 3 days: Gradually distribute participants with rice flour, porridge and juice.

prolonged fasting

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old, no nationality limitation, no gender limitation;
  • Male weight ≥ 50 kg, female weight ≥ 45 kg;BMI: 19-28 kg/m²;
  • The index of physical examination is in line with health standards;
  • People who have gone through a 7-day fasting before ;
  • Agree to take part in the trials and sign the informed consent form.

You may not qualify if:

  • People with unhealthy habits, such as smoking(5 cigarettes per day, or can not stop smoking in the trial), excessive drinking(drink regularly in the recent 6 months or more than 14 units of alcohol per week (1 unit = 360 ml beer or 45 ml alcohol with 40% spirits or 150 ml wine)) ;
  • People who processed fasting within one month;
  • Pregnancy, current breast-feeding or menstrual period;
  • People who are marantic, malnourished or anorectic;
  • People who have cardiovascular disease(coronary heart disease, atherosclerosis, arrhythmia, etc), serious metabolic and psychiatric disorders(hypertension, type 2 diabetes, hyperthyroidism, etc.);
  • People who have Mental illness, cancer, hepatitis B surface antigen (HBsAg), hepatitis C virus (HCV), syphilis, human immunodeficiency virus (HIV) antibody positive.
  • people who has mental disorders according to the scales(Hamilton Anxiety Scale、Self-Rating Anxiety Scale、Self-rating depression scale)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, 200030, China

Location

MeSH Terms

Conditions

FastingMotor Activity

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Officials

  • Lijun Jia, Ph.D.

    Shanghai University of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2018

First Posted

November 27, 2018

Study Start

September 9, 2018

Primary Completion

April 9, 2019

Study Completion

September 9, 2019

Last Updated

December 4, 2018

Record last verified: 2018-10

Locations